Tivic Health Systems, Inc. ( (TIVC) ) has released its Q3 earnings. Here is a breakdown of the information Tivic Health Systems, Inc. presented to its investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Tivic Health Systems, Inc. is a Delaware-based company specializing in the development and commercialization of non-invasive bioelectronic medicine, with a focus on sinus pain relief devices. Recently, Tivic Health Systems released its earnings report for the quarter ending September 30, 2024, highlighting significant financial metrics and developments. The company reported a decrease in revenue to $126,000 for the quarter, down from $282,000 in the same period last year. Operating expenses also decreased, contributing to a reduced net loss of $1.43 million compared to $1.76 million in the previous year. The company continues to face challenges due to its negative cash flows and net losses, raising concerns about its ability to continue as a going concern. Looking ahead, Tivic Health Systems anticipates the need for additional capital to support its research and development activities, with plans to explore equity or debt offerings to finance future growth and operations.
